High fibrin and platelet clot predicts stroke recurrence or mortality after thrombectomy in patients with active cancer.

Among stroke patients receiving EVT, thrombi with a higher percentage of FP not only identify individuals with active cancer but also predict stroke recurrence or mortality within 90 days.